This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
neurofibromatosis-type-2
Neurofibromatosis Type 2
Neurofibromatosis type 2 (NF2) is caused by germline NF2 mutations; bilateral vestibular schwannomas are pathognomonic; meningiomas, ependymomas also occur; merlin activates Hippo-YAP1; bevacizumab improves hearing; TEAD inhibitors in clinical trials.
Entry Metadata
| Field | Value |
|---|---|
| ID | neurofibromatosis-type-2 |
| Name | Neurofibromatosis Type 2 |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Asthagiri AR, Parry DM, Butman JA, et al. Neurofibromatosis type 2. Lancet. 2009;373(9679):1974-1986. · PubMed 19476995
- Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med. 2009;361(4):358-367. · PubMed 19587327